Walker Neal
Insider CIK 1604457 · ALDX Director · ACRS President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 3,318 | — | $0 | 3,318 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 70,000 | — | $0 | 70,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-02-03 | 2026-02-05 | 63,475 | — | $0 | 190,425 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2026-02-03 | 2026-02-05 | 18,611 | $3.47 | $64.6K | 1,543,886 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-02-03 | 2026-02-05 | 63,475 | — | $0 | 1,562,497 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-06 | 961,700 | — | $0 | 961,700 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2026-02-02 | 2026-02-06 | 274,800 | — | $0 | 274,800 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2026-01-02 | 2026-01-05 | 29,150 | — | $0 | 30,034 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2026-01-02 | 2026-01-05 | 9,952 | $2.88 | $28.7K | 1,499,022 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2026-01-02 | 2026-01-05 | 29,150 | — | $0 | 1,508,974 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 2,413 | — | $0 | 2,413 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-12 | 62,728 | — | $0 | 62,728 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-05-01 | 2025-05-05 | 9,467 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-05-01 | 2025-05-05 | 2,975 | $1.38 | $4.1K | 1,479,824 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-05-01 | 2025-05-05 | 9,467 | — | $0 | 1,482,799 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-04-01 | 2025-04-03 | 9,467 | — | $0 | 9,467 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-04-01 | 2025-04-03 | 9,467 | — | $0 | 1,476,374 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-04-01 | 2025-04-03 | 3,042 | $1.48 | $4.5K | 1,473,332 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-03-01 | 2025-03-04 | 9,466 | — | $0 | 18,934 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-03-01 | 2025-03-04 | 9,466 | — | $0 | 1,470,184 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-03-01 | 2025-03-04 | 3,277 | $1.99 | $6.5K | 1,466,907 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-04 | 888,800 | — | $0 | 888,800 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-02-03 | 2025-02-04 | 253,900 | — | $0 | 253,900 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-02-01 | 2025-02-04 | 9,467 | — | $0 | 28,400 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-02-01 | 2025-02-04 | 9,467 | — | $0 | 1,464,277 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-02-01 | 2025-02-04 | 3,559 | $2.48 | $8.8K | 1,460,718 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2025-01-02 | 2025-01-03 | 88,333 | — | $0 | 88,333 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-01-02 | 2025-01-03 | 29,149 | — | $0 | 59,184 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-01-02 | 2025-01-03 | 29,149 | — | $0 | 1,468,342 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-01-02 | 2025-01-03 | 13,532 | $2.48 | $33.6K | 1,454,810 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2025-01-01 | 2025-01-03 | 9,467 | — | $0 | 37,867 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2025-01-01 | 2025-01-03 | 3,904 | $2.48 | $9.7K | 1,439,193 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2025-01-01 | 2025-01-03 | 9,467 | — | $0 | 1,443,097 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-12-04 | 2024-12-06 | 118,840 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-12-04 | 2024-12-06 | 68,343 | $3.76 | $257.0K | 1,433,630 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-12-04 | 2024-12-06 | 118,840 | $1.52 | $180.6K | 1,501,973 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-12-01 | 2024-12-03 | 9,466 | — | $0 | 47,334 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-12-01 | 2024-12-03 | 2,721 | $4.07 | $11.1K | 1,383,133 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-12-01 | 2024-12-03 | 9,466 | — | $0 | 1,385,854 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-11-01 | 2024-11-05 | 9,467 | — | $0 | 56,800 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-11-01 | 2024-11-05 | 9,467 | — | $0 | 1,379,109 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-11-01 | 2024-11-05 | 2,721 | $2.09 | $5.7K | 1,376,388 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-10-01 | 2024-10-03 | 9,467 | — | $0 | 66,267 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-10-01 | 2024-10-03 | 2,722 | $1.18 | $3.2K | 1,369,642 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-10-01 | 2024-10-03 | 9,467 | — | $0 | 1,372,364 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-09-01 | 2024-09-04 | 9,466 | — | $0 | 75,734 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-09-01 | 2024-09-04 | 2,722 | $1.18 | $3.2K | 1,362,897 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-09-01 | 2024-09-04 | 9,466 | — | $0 | 1,365,619 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-08-09 | 2024-08-13 | 43,548 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-08-09 | 2024-08-13 | 43,548 | $0.72 | $31.4K | 1,356,153 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-08-01 | 2024-08-05 | 9,467 | — | $0 | 85,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-08-01 | 2024-08-05 | 2,722 | $1.32 | $3.6K | 1,312,605 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-08-01 | 2024-08-05 | 9,467 | — | $0 | 1,315,327 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-07-01 | 2024-07-03 | 9,467 | — | $0 | 94,667 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-07-01 | 2024-07-03 | 2,722 | $1.15 | $3.1K | 1,305,860 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-07-01 | 2024-07-03 | 9,467 | — | $0 | 1,308,582 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 1,736 | — | $0 | 1,736 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2024-06-04 | 2024-06-06 | 40,282 | — | $0 | 40,282 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-06-01 | 2024-06-04 | 9,466 | — | $0 | 104,134 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-06-01 | 2024-06-04 | 9,466 | — | $0 | 1,301,837 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-06-01 | 2024-06-04 | 2,722 | $1.03 | $2.8K | 1,299,115 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-05-01 | 2024-05-03 | 9,467 | — | $0 | 113,600 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-05-01 | 2024-05-03 | 9,467 | — | $0 | 1,295,155 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-05-01 | 2024-05-03 | 2,784 | $1.26 | $3.5K | 1,292,371 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-04-01 | 2024-04-03 | 9,467 | — | $0 | 123,067 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-04-01 | 2024-04-03 | 9,467 | — | $0 | 1,288,912 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-04-01 | 2024-04-03 | 3,224 | $1.26 | $4.1K | 1,285,688 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2024-03-01 | 2024-03-05 | 9,466 | — | $0 | 132,534 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2024-03-01 | 2024-03-05 | 3,223 | $1.24 | $4.0K | 1,279,445 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2024-03-01 | 2024-03-05 | 9,466 | — | $0 | 1,282,668 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 142,000 | — | $0 | 142,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2024-02-01 | 2024-02-05 | 497,000 | — | $0 | 497,000 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise deriv | 2023-08-22 | 2023-08-24 | 9,604 | — | $0 | 0 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | M Exercise | 2023-08-22 | 2023-08-24 | 9,604 | $0.55 | $5.3K | 15,854 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 915 | — | $0 | 915 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2023-06-30 | 2023-07-05 | 21,222 | — | $0 | 21,222 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-03-03 | 2023-03-03 | 30,240 | $12.63 | $381.9K | 1,273,202 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-02 | 2023-03-03 | 18,254 | — | $0 | 18,254 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-03-02 | 2023-03-03 | 29,000 | $12.37 | $358.7K | 1,285,188 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-02 | 2023-03-03 | 18,254 | — | $0 | 1,303,442 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-01 | 2023-03-03 | 18,275 | — | $0 | 36,550 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-01 | 2023-03-03 | 96,150 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2023-03-01 | 2023-03-03 | 24,000 | — | $0 | 72,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-01 | 2023-03-03 | 96,150 | — | $0 | 1,271,913 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-01 | 2023-03-03 | 18,275 | — | $0 | 1,290,188 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2023-03-01 | 2023-03-03 | 24,000 | — | $0 | 1,314,188 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-02-02 | 2023-02-03 | 200 | $17.54 | $3.5K | 1,175,763 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-02-02 | 2023-02-03 | 1,079 | $14.57 | $15.7K | 1,179,684 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-02-02 | 2023-02-03 | 600 | $15.55 | $9.3K | 1,179,084 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-02-02 | 2023-02-03 | 3,121 | $16.88 | $52.7K | 1,175,963 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-02-01 | 2023-02-03 | 25,000 | $16.75 | $418.8K | 1,180,763 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-01-04 | 2023-01-04 | 15,000 | $14.89 | $223.3K | 1,205,763 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-01-03 | 2023-01-04 | 1,618 | $16.16 | $26.1K | 1,220,763 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2023-01-03 | 2023-01-04 | 23,382 | $15.19 | $355.2K | 1,222,381 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 53,812 | — | $0 | 53,812 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2022-06-07 | 2022-06-09 | 2,319 | — | $0 | 2,319 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-04-25 | 2022-04-25 | 20,000 | $15.18 | $303.6K | 1,245,763 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-04-22 | 2022-04-25 | 25,000 | $15.04 | $376.0K | 1,265,763 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-04-21 | 2022-04-25 | 25,000 | $15.24 | $381.0K | 1,290,763 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-03-11 | 2022-03-14 | 56,303 | $15.91 | $895.8K | 1,315,763 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-03-02 | 2022-03-03 | 18,254 | — | $0 | 36,508 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-03-02 | 2022-03-03 | 18,254 | — | $0 | 1,372,066 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 18,275 | — | $0 | 54,825 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-03-01 | 2022-03-03 | 96,150 | — | $0 | 96,150 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 336,100 | — | $0 | 336,100 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2022-03-01 | 2022-03-03 | 96,000 | — | $0 | 96,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-03-01 | 2022-03-03 | 18,275 | — | $0 | 1,353,812 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-03-01 | 2022-03-03 | 96,150 | — | $0 | 1,335,537 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2022-02-09 | 2022-02-11 | 3,595 | $12.66 | $45.5K | 1,239,387 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2022-02-01 | 2022-02-03 | 10,800 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2022-02-01 | 2022-02-03 | 10,800 | — | $0 | 1,242,982 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2021-06-08 | 2021-06-10 | 13,534 | — | $0 | 13,534 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2021-06-08 | 2021-06-10 | 583 | — | $0 | 583 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 5,517 | $22.30 | $123.0K | 1,232,182 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 27,743 | $21.51 | $596.8K | 1,237,699 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-06-01 | 2021-06-02 | 73,015 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-06-01 | 2021-06-02 | 73,015 | — | $0 | 1,265,442 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-04-22 | 2021-04-26 | 30,000 | $26.84 | $805.2K | 1,192,427 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-03-02 | 2021-03-03 | 18,253 | — | $0 | 54,762 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-03-02 | 2021-03-03 | 18,253 | — | $0 | 1,230,409 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-03-02 | 2021-03-03 | 7,982 | $23.25 | $185.6K | 1,222,427 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 96,150 | — | $0 | 192,300 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 255,800 | — | $0 | 255,800 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 73,100 | — | $0 | 73,100 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-03-01 | 2021-03-03 | 96,150 | — | $0 | 1,251,948 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-03-01 | 2021-03-03 | 39,792 | $24.06 | $957.4K | 1,212,156 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-02-01 | 2021-02-03 | 10,800 | — | $0 | 10,800 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-02-01 | 2021-02-03 | 10,800 | — | $0 | 1,159,114 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-02-01 | 2021-02-03 | 3,316 | $21.35 | $70.8K | 1,155,798 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-12-15 | 2020-12-17 | 3,034 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-12-15 | 2020-12-17 | 3,034 | — | $0 | 1,149,185 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-12-15 | 2020-12-17 | 871 | $4.59 | $4.0K | 1,148,314 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-09-01 | 2020-09-03 | 83,092 | — | $0 | 83,092 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-09-01 | 2020-09-03 | 83,092 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-09-01 | 2020-09-03 | 83,092 | — | $0 | 1,170,023 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-09-01 | 2020-09-03 | 23,872 | $2.33 | $55.6K | 1,146,151 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 1,541 | — | $0 | 1,541 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 26,503 | — | $0 | 26,503 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-06-01 | 2020-06-03 | 73,014 | — | $0 | 73,015 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-06-01 | 2020-06-03 | 73,014 | — | $0 | 1,107,907 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-06-01 | 2020-06-03 | 20,976 | $1.32 | $27.7K | 1,086,931 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 146,029 | — | $0 | 146,029 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-03-02 | 2020-03-04 | 96,150 | — | $0 | 288,450 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 52,564 | — | $0 | 52,564 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 73,015 | — | $0 | 73,015 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-03-02 | 2020-03-04 | 52,564 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 255,552 | — | $0 | 255,552 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-03-02 | 2020-03-04 | 15,101 | $1.26 | $19.0K | 1,034,893 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-03-02 | 2020-03-04 | 52,564 | — | $0 | 1,049,994 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-03-02 | 2020-03-04 | 27,623 | $1.26 | $34.8K | 997,430 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-03-02 | 2020-03-04 | 96,150 | — | $0 | 1,025,053 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-02-03 | 2020-02-04 | 10,800 | — | $0 | 21,600 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-02-03 | 2020-02-04 | 10,800 | — | $0 | 932,578 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-02-03 | 2020-02-04 | 3,675 | $1.28 | $4.7K | 928,903 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-12-18 | 2019-12-20 | 2,925 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-12-18 | 2019-12-20 | 743 | $1.81 | $1.3K | 921,778 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-12-18 | 2019-12-20 | 2,925 | — | $0 | 922,521 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-12-16 | 2019-12-18 | 3,033 | — | $0 | 3,034 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-12-16 | 2019-12-18 | 782 | $1.80 | $1.4K | 919,596 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-12-16 | 2019-12-18 | 3,033 | — | $0 | 920,378 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2019-06-04 | 2019-06-06 | 18,951 | — | $0 | 18,951 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2019-06-04 | 2019-06-06 | 1,102 | — | $0 | 1,102 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2019-03-01 | 2019-03-04 | 384,600 | — | $0 | 384,600 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-02-01 | 2019-02-05 | 10,800 | — | $0 | 32,400 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-02-01 | 2019-02-05 | 3,579 | $6.96 | $24.9K | 917,345 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-02-01 | 2019-02-05 | 10,800 | — | $0 | 920,924 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-12-18 | 2018-12-21 | 2,925 | — | $0 | 2,925 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-12-18 | 2018-12-21 | 833 | $6.30 | $5.2K | 910,124 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-12-18 | 2018-12-21 | 2,925 | — | $0 | 910,957 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-12-15 | 2018-12-18 | 3,033 | — | $0 | 6,067 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-12-15 | 2018-12-18 | 863 | $7.31 | $6.3K | 908,032 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-12-15 | 2018-12-18 | 3,033 | — | $0 | 908,895 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 903 | — | $0 | 903 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 15,526 | — | $0 | 15,526 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2018-05-07 | 2018-05-09 | 12,133 | — | $0 | 9,100 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2018-05-07 | 2018-05-09 | 12,133 | — | $0 | 909,317 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2018-05-07 | 2018-05-09 | 3,455 | $18.10 | $62.5K | 905,862 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | P Buy | 2018-04-05 | 2018-04-09 | 10,000 | $16.75 | $167.5K | 897,184 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2018-03-16 | 2018-03-20 | 9,018 | — | $0 | 887,184 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 43,200 | — | $0 | 43,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2018-02-01 | 2018-02-05 | 151,200 | — | $0 | 151,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2017-12-18 | 2017-12-21 | 2,925 | — | $0 | 5,850 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2017-12-18 | 2017-12-21 | 889 | $24.12 | $21.4K | 878,166 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2017-12-18 | 2017-12-21 | 2,925 | — | $0 | 879,055 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2017-12-15 | 2017-12-21 | 3,033 | — | $0 | 21,233 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2017-12-15 | 2017-12-21 | 922 | $24.23 | $22.3K | 876,130 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2017-12-15 | 2017-12-21 | 3,033 | — | $0 | 877,052 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2017-06-08 | 2017-06-12 | 1,481 | — | $0 | 1,481 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2017-06-08 | 2017-06-12 | 17,776 | — | $0 | 17,776 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2016-12-18 | 2016-12-20 | 2,925 | — | $0 | 8,775 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2016-12-18 | 2016-12-20 | 889 | $31.25 | $27.8K | 874,019 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2016-12-18 | 2016-12-20 | 2,925 | — | $0 | 874,908 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-19 | 145,600 | — | $0 | 145,600 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2016-12-15 | 2016-12-19 | 24,266 | — | $0 | 24,266 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2016-09-15 | 2016-09-19 | 81,686 | — | $0 | 867,193 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | J Other | 2016-09-15 | 2016-09-19 | 4,790 | — | $0 | 871,983 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2016-06-09 | 2016-06-10 | 6,083 | — | $0 | 6,083 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 137,335 | — | $0 | 137,335 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2015-12-18 | 2015-12-22 | 11,700 | — | $0 | 11,700 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2015-06-09 | 2015-06-10 | 6,083 | — | $0 | 6,083 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | A Award deriv | 2014-05-07 | 2014-05-08 | 12,166 | — | $0 | 12,166 | SEC↗ |
| ALDX Aldeyra Therapeutics, Inc. | P Buy | 2014-05-07 | 2014-05-08 | 6,250 | $8.00 | $50.0K | 6,250 | SEC↗ |